TrialDiabetes, obesity & metabolism2017

Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial.

Per-Henrik Groop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.